Skip to main content

Lion Point Capital, LP

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 1643354 NEW YORK, NY

Position in FENC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,208,665
+$517,196 QoQ
Shares Held
112,434
0.0% QoQ
Ownership
0.321%
of shares outstanding
% of Portfolio
5.78%
of 13F equity value
Holder Rank
#20
of 104 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FENC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Lion Point Capital, LP holds $18,132,915 across 30 Biotechnology names. FENC ranks #4 (6.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 FENC
Fennec Pharmaceuticals Inc.
This page
112,434 $1,208,665

All Filings in FENC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,208,665 112,434
2026-03-31 $691,469 112,434
2025-12-31 $865,741 112,434
2025-09-30 $1,151,280 123,000
2025-06-30 $1,624,310 195,700
2025-03-31 $1,191,813 195,700
2024-12-31 $1,236,824 195,700
2024-09-30 $1,075,000 215,000
2024-06-30 $1,038,700 170,000
2024-03-31 $1,890,400 170,000
2023-12-31 $1,234,200 110,000
2023-09-30 $826,100 110,000
2023-06-30 $971,300 110,000